These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2821461)

  • 41. [The effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with chronic glomerulonephritis and pronounced kidney failure].
    Diadyk AI; Bagriĭ AE; Lebed' IA; Iarovaia NF; Shchukina EV; Gaĭdukov VO; Gritsenko PV; Diadyk IA
    Ter Arkh; 1997; 69(6):24-7. PubMed ID: 9297267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lisinopril for hypertension.
    Med Lett Drugs Ther; 1988 Apr; 30(763):41-2. PubMed ID: 2832713
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
    MMW Fortschr Med; 2002 Jun; 144(24):53. PubMed ID: 12138889
    [No Abstract]   [Full Text] [Related]  

  • 44. Cough induced by enalapril but not by captopril.
    Puolijoki H; Nieminen M; Moilanen E; Siitonen L; Lahdensuo A; Reinikainen P; Vapaatalo H
    Eur Respir J; 1989 Mar; 2(3):289-91. PubMed ID: 2543598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in red blood cell glutathione and glutathione-dependent enzymes on long-term treatment with captopril and enalapril.
    Golik A; Weissgarten J; Evans S; Cohen N; Zaidenstein R; Modai D; Cotariu D
    Clin Chim Acta; 1995 Aug; 240(1):89-94. PubMed ID: 8582063
    [No Abstract]   [Full Text] [Related]  

  • 46. [Inhibition of angiotensin converting enzyme as a therapeutic approach: the pros and cons].
    Waeber B; Waeber G; Nussberger J; Brunner HR
    Rev Med Brux; 1986 Apr; 7(4):227-30. PubMed ID: 3014629
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mechanisms of action and clinical use of converting enzyme inhibitors].
    Lazowski J; Rewerski W
    Pol Tyg Lek; 1986 Dec; 41(48):1507-11. PubMed ID: 3035518
    [No Abstract]   [Full Text] [Related]  

  • 48. Angiotensin converting enzyme inhibitors and cough--a north Indian study.
    Singh NP; Uppal M; Anuradha S; Agarwal A; Rizvi SN
    J Assoc Physicians India; 1998 May; 46(5):448-51. PubMed ID: 11273288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New momentum in cardiovascular therapy. Further development of ACE inhibitors: from captopril to lisinopril].
    Fortschr Med Suppl; 1988; 48():1-11. PubMed ID: 2904396
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hospital intensive monitoring of adverse reactions of ACE inhibitors].
    Mangrella M; Motola G; Russo F; Mazzeo F; Giassa T; Falcone G; Rossi F; D'Alessio O; Rossi F
    Minerva Med; 1998 Apr; 89(4):91-7. PubMed ID: 9676174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tolerability of enalapril in mild to moderate hypertension.
    Sharma S; Gupta U; Bapna JS; Sahai A
    J Assoc Physicians India; 1995 Jul; 43(7):475-6. PubMed ID: 8713222
    [No Abstract]   [Full Text] [Related]  

  • 52. The use of angiotensin converting enzyme inhibitors in elderly patients with hypertension.
    Chobanian AV
    J Am Geriatr Soc; 1987 Mar; 35(3):269-70. PubMed ID: 3029205
    [No Abstract]   [Full Text] [Related]  

  • 53. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE; Sjöstrand A; Ohman KP
    J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selenium-dependent GSH-Px in erythrocytes of patients with hypertension treated with ACE inhibitors.
    Djordjević VB; Grubor-Lajsić G; Jovanovic-Galović A; Pavlović D; Cvetković T; Pejović M; Lecić N
    J Environ Pathol Toxicol Oncol; 1998; 17(3-4):277-80. PubMed ID: 9726802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volunteers.
    Ebert U; Kirch W
    Eur J Clin Pharmacol; 1999 Jun; 55(4):255-7. PubMed ID: 10424316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renpress, Sandopril (Spirapril/TI 211-950). Summary of chemical, pharmacological and clinical properties.
    Jerie P; Kremer HJ
    Cor Vasa; 1992; 34(1):82-7. PubMed ID: 1288944
    [No Abstract]   [Full Text] [Related]  

  • 58. [Inhibitors of the conversion enzyme and glycoregulation].
    Richard JL; Ferrière M; Bringer J; Mirouze J
    Diabete Metab; 1990; 16(3):265-6. PubMed ID: 2210026
    [No Abstract]   [Full Text] [Related]  

  • 59. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
    Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
    Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.